Skip to main content

1 Result(s)

within Maria Font Pous Remove this filter

and

  1. No Access

    Article

    Risk Management Plans: are they a tool for improving drug safety?

    In 2005, new European legislation authorised Regulatory Agencies to require drug companies to submit a risk management plan (RMP) comprising detailed commitments for post-marketing pharmacovigilance. The aim o...

    Serena Frau, Maria Font Pous… in European Journal of Clinical Pharmacology (2010)